Connecticut Opens Psychedelic Therapy Pilot To More Adults As Demand Grows
Connecticut is widening access to a medical psychedelic therapy program at a moment when public interest has clearly outpaced availability.
Read Morelisteo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170
Connecticut is widening access to a medical psychedelic therapy program at a moment when public interest has clearly outpaced availability.
Read More
A new review in Hearing Research suggests psilocybin may one day help researchers target tinnitus in a different way.
Read More
The mushroom, Lanmaoa asiatica, has been linked to visions of miniature people. The story sounds folkloric, but the science behind it isn't.
Read More
Intravenous ketamine reduced suicidal and depressive symptoms quickly, sometimes within hours. That matters.
Read More
A new narrative review argues that ketamine dosing should be rethought. An anesthesia dose, a pain dose and a psychiatric dose are not equal.
Read More
Psychedelics are no longer a fringe topic among veterans. They are part of the lived experience of millions of those who serve in the military.
Read More
One of the country’s most influential anesthesia groups is warning that ketamine telehealth's safety standards have not kept pace.
Read More
Ketamine is often described through one clean mechanism. But a new study shows the science behind its effects may be broader than we thought.
Read More
Definium Therapeutics LSD based pill, DT120 ODT, reduced depression symptoms in a phase 3 trial of adults with major depressive disorder.
Read More
Scientists at the University of California, Berkeley want to know whether psilocybin can help the brain age with more flexibility.
Read More